BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Prozac
,
rs2476601
,
FOXP1
,
Fatty acid metabolic process
,
Lung cancer
,
Endothelial cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
liver%20cancer
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
GPC3
CLEC1B
CYP1A2
HAMP
FCN3
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
DODD_NASOPHARYNGEAL_CARCINOMA_DN
PATIL_LIVER_CANCER
heterocyclic compound binding
cytosol
organic cyclic compound binding
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Induction of cancer cell stemness in glioma through glycolysis and the long noncoding RNA HULC-activ…
Long noncoding RNA HULC promotes hepatocellular carcinoma progression.
Long non-coding RNA HULC exerts oncogenic activity on papillary thyroid cancer in vitro and in vivo.
LncRNA HULC promotes the progression of gastric cancer by regulating miR-9-5p/MYH9 axis.
Liver X receptor inhibits the growth of hepatocellular carcinoma cells via regulating HULC/miR-134-5…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cance…
An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer
Study Of Sunitinib Malate Versus Sorafenib In Patients With Inoperable Liver Cancer
Hepatic Impairment Study For Crizotinib In Advanced Cancer Patients
MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ